cromakalim has been researched along with bms 180448 in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 14 (77.78) | 18.2507 |
2000's | 4 (22.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carroll, WA; Coghlan, MJ; Gopalakrishnan, M | 1 |
Atwal, KS; D'Alonzo, AJ; Grover, GJ; McCullough, JR; Sargent, CA | 1 |
Atwal, KS | 1 |
Grover, GJ | 2 |
Ahmed, SZ; Atwal, KS; Dzwonczyk, S; Ferrara, FN; Grover, GJ; Harper, TW; Kim, KS; Moreland, S; Russell, AD; Sleph, PG | 1 |
D'Alonzo, AJ; Darbenzio, RB; Grover, GJ; Hess, T; Sleph, PG | 1 |
Grover, GJ; Sleph, PG | 1 |
D'Alonzo, AJ; Darbenzio, RB; Grover, GJ; Hess, TA; Lodge, NJ; Normandin, DE; Sewter, JC; Sleph, PG | 1 |
D'Alonzo, AJ; Darbenzio, RB; Dzwonczyk, S; Grover, GJ; Hess, TA; Sewter, JC; Sleph, PG | 1 |
Gomoll, AW; Weselcouch, EO | 1 |
Carr, CS; Yellon, DM | 1 |
Atwal, KS; Bajgar, R; D'Alonzo, AJ; Darbenzio, RB; Garlid, KD; Grover, GJ; Hess, TA; Lodge, NJ; Paucek, P; Sleph, PG; Smith, MA | 1 |
Ahmed, SZ; Atwal, KS; Baird, AJ; Dzwonczyk, S; Grover, GJ; Normandin, DE; Sleph, PG | 1 |
Ahmed, SZ; Atwal, KS; Baird, AJ; Ding, CZ; Dzwonczyk, S; Ferrara, FN; Grover, GJ; Humphreys, WG; McLaughlin, LG; Normandin, DE; Rovnyak, GC; Santafianos, D; Sleph, PG; Traeger, SC | 1 |
Ahmed, SZ; Atwal, KS; Ding, CZ; Grover, GJ; Kelly, Y; Miller, AV; Misra, RN; Normandin, DE; Rovnyak, GC; Sleph, PG | 1 |
Atwal, KS; Ferrara, FN; Green, DW; Grover, GJ; Monshizadegan, H; Rogers, WL; Sleph, P; Traeger, S; Wang, P | 1 |
Balsamo, A; Bianucci, AM; Calderone, V; Coi, A; Digiacomo, M; Rapposelli, S; Testai, L | 1 |
4 review(s) available for cromakalim and bms 180448
Article | Year |
---|---|
Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.
Topics: Adenosine Triphosphate; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Calcium; Ion Channel Gating; Myocardial Ischemia; Potassium Channel Blockers; Potassium Channels; Urinary Incontinence | 2001 |
Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Antihypertensive Agents; Benzopyrans; Cardiovascular Diseases; Cromakalim; Diazoxide; Guanidines; Guinea Pigs; Minoxidil; Muscle Relaxation; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Picolines; Pinacidil; Potassium Channels; Pyrans; Pyrroles; Radioligand Assay; Rats; Structure-Activity Relationship; Vasodilator Agents | 1994 |
Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Dihydropyridines; Disease Models, Animal; Dogs; Guanidines; Guinea Pigs; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Picolines; Pinacidil; Potassium Channels; Pyrans; Pyrroles; Rats; Vasodilator Agents | 1994 |
Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion.
Topics: Animals; ATP-Binding Cassette Transporters; Benzopyrans; Cromakalim; Guanidines; Humans; Ischemic Preconditioning, Myocardial; KATP Channels; Mitochondria, Heart; Models, Cardiovascular; Myocardial Ischemia; Myocardial Reperfusion; Niacinamide; Nicorandil; Picolines; Pinacidil; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pyrans; Pyrroles; Rats | 1997 |
14 other study(ies) available for cromakalim and bms 180448
Article | Year |
---|---|
Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Aorta; Benzopyrans; Cromakalim; Decanoic Acids; Dogs; Female; Glyburide; Guanidines; Guinea Pigs; Heart; Heart Ventricles; Hydroxy Acids; In Vitro Techniques; Injections, Intravenous; Injections, Subcutaneous; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardial Ischemia; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1995 |
Cardioselective anti-ischemic ATP-sensitive potassium channel openers.
Topics: Adenosine Triphosphate; Animals; Aorta; Benzopyrans; Biological Availability; Cocaine; Cromakalim; Guanidines; Ion Channel Gating; Molecular Structure; Myocardial Ischemia; Potassium Channels; Pyrroles; Rats; Structure-Activity Relationship; Vasodilation | 1993 |
Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Female; Glyburide; Guanidines; Guinea Pigs; In Vitro Techniques; Ion Channel Gating; Male; Membrane Potentials; Myocardial Infarction; Myocardial Ischemia; Perfusion; Potassium Channels; Pyrroles; Vasodilator Agents | 1995 |
Protective effect of K(ATP) openers in ischemic rat hearts treated with a potassium cardioplegic solution.
Topics: Adenosine Triphosphate; Animals; Benzopyrans; Cardioplegic Solutions; Cromakalim; Guanidines; Heart; Male; Myocardial Ischemia; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley | 1995 |
A comparison between the effects of BMS-180448, a novel K+ channel opener, and cromakalim in rat and dog.
Topics: Animals; Anti-Arrhythmia Agents; Aorta, Thoracic; Benzopyrans; Blood Pressure; Cardiotonic Agents; Cromakalim; Dogs; Electrophysiology; Guanidines; Heart; Heart Conduction System; Heart Rate; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Myocardial Ischemia; Potassium Channels; Pyrroles; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Species Specificity | 1995 |
Hemodynamic and cardiac effects of BMS-180448, a novel K+ATP opener, in anesthetized dogs and isolated rat hearts.
Topics: Adenosine Triphosphate; Anesthesia; Animals; Benzopyrans; Blood Pressure; Coronary Circulation; Cromakalim; Dogs; Dose-Response Relationship, Drug; Female; Guanidines; Heart; Heart Rate; Hemodynamics; In Vitro Techniques; Male; Myocardial Contraction; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vascular Resistance | 1996 |
Selectivity of BMS-180448 on myocardial versus brain blood flow in dogs and ferrets.
Topics: Adenosine Triphosphate; Animals; Benzopyrans; Cerebrovascular Circulation; Coronary Circulation; Cromakalim; Dogs; Electrophysiology; Ferrets; Guanidines; Hemodynamics; Male; Potassium Channels; Pyrroles; Vasodilator Agents | 1997 |
Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle.
Topics: Adenosine Triphosphate; Adult; Aged; Angina Pectoris; Benzopyrans; Cromakalim; Female; Guanidines; Heart Atria; Humans; Ischemic Preconditioning, Myocardial; Male; Middle Aged; Myocardial Contraction; Niacinamide; Nicorandil; Potassium Channels; Vasodilator Agents | 1997 |
Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
Topics: Action Potentials; Animals; Benzopyrans; Cardiovascular Agents; Cromakalim; Decanoic Acids; Dose-Response Relationship, Drug; Glyburide; Guanidines; Guinea Pigs; Heart; Heart Conduction System; Hydroxy Acids; Imidazoles; In Vitro Techniques; Male; Mitochondria; Myocardial Ischemia; Myocardial Reperfusion; Papillary Muscles; Patch-Clamp Techniques; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Vasodilator Agents; Vasomotor System | 2001 |
Cardioselective anti-ischemic ATP-sensitive potassium channel openers. 3. Structure-activity studies on benzopyranyl cyanoguanidines: modification of the cyanoguanidine portion.
Topics: Adenosine Triphosphate; Animals; Guanidines; In Vitro Techniques; Magnetic Resonance Spectroscopy; Myocardial Ischemia; Potassium Channels; Rats; Structure-Activity Relationship; Vasodilator Agents | 1995 |
Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 5. Identification of 4-(N-aryl)-substituted benzopyran derivatives with high selectivity.
Topics: Adenosine Triphosphate; Animals; Benzopyrans; Biological Availability; Glyburide; Heart; Potassium Channels; Rats; Structure-Activity Relationship | 1997 |
Cardioselective antiischemic ATP-sensitive potassium channel (K(ATP)) openers. 6. Effect of modifications at C6 of benzopyranyl cyanoguanidines.
Topics: Animals; Benzopyrans; Cardiotonic Agents; Glyburide; Guanidines; Heart; Muscle Contraction; Myocardial Ischemia; Potassium Channels; Rats; Vasodilation; Vasodilator Agents | 1999 |
Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitors.
Topics: Adenosine Triphosphate; Animals; Benzopyrans; Cardiotonic Agents; Cattle; Citrate (si)-Synthase; Electron Transport Complex IV; Hydrolysis; Imidazoles; In Vitro Techniques; Mitochondrial Proton-Translocating ATPases; Myocardial Contraction; Rats; Stereoisomerism; Structure-Activity Relationship | 2004 |
Predictive models, based on classification algorithms, for compounds potentially active as mitochondrial ATP-sensitive potassium channel openers.
Topics: Algorithms; Benzopyrans; Cardiotonic Agents; KATP Channels; Models, Chemical; Molecular Structure; Quantitative Structure-Activity Relationship; Spiro Compounds | 2009 |